Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients ; volume:15 ; number:1 ; day:14 ; month:4 ; year:2014 ; pages:1-7 ; date:12.2014
BMC pharmacology & toxicology ; 15, Heft 1 (14.4.2014), 1-7, 12.2014
- Urheber
-
Goncalves-Pereira, João
- Beteiligte Personen und Organisationen
-
Silva, Nuno Elvas
Mateus, André
Pinho, Catarina
Póvoa, Pedro
SpringerLink (Online service)
- DOI
-
10.1186/2050-6511-15-21
- URN
-
urn:nbn:de:1111-2016071828268
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goncalves-Pereira, João
- Silva, Nuno Elvas
- Mateus, André
- Pinho, Catarina
- Póvoa, Pedro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Population pharmacokinetics of meropenem in critically ill patients
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock
Surgical treatment of spondylodiscitis in critically ill septic patients
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Endoscopic guide wire gallbladder decompression in a critically ill, septic patient
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
BK viremia in critically ill surgical patients with hemorrhagic or septic shock
BK viremia in critically ill surgical patients with hemorrhagic or septic shock
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Population pharmacokinetics of meropenem in critically ill patients
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock
Surgical treatment of spondylodiscitis in critically ill septic patients
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Endoscopic guide wire gallbladder decompression in a critically ill, septic patient
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
BK viremia in critically ill surgical patients with hemorrhagic or septic shock
BK viremia in critically ill surgical patients with hemorrhagic or septic shock
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Population pharmacokinetics of meropenem in critically ill patients
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock
Surgical treatment of spondylodiscitis in critically ill septic patients
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Endoscopic guide wire gallbladder decompression in a critically ill, septic patient
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
BK viremia in critically ill surgical patients with hemorrhagic or septic shock